With a commitment on turning good ideas into innovative, effective medicines for many unmet health needs, AstraZeneca is establishing a global research center in Shanghai: the Innovation Center China (ICC). The initial research area for ICC will be cancer research, with focus on translational science by developing knowledge about Chinese patients, discovering biomarkers for personalized medical needs and better understanding drug mechanisms of action for targeted therapies.

    As a newly established global research center, ICC provides many excellent scientific research opportunities in a highly stimulating, diverse scientific environment and a competitive career development path. ICC offers competitive salaries, compensation and benefits programs.